Home›Stock Screener›Onesource Specialty Pharma›Quarterly Results

Onesource Specialty Pharma Quarterly Results

Latest Quarter Net Profit
₹5 Cr
QMar 2026
Quarterly Results

Onesource Specialty Pharma quarterly results. In Mar 2026, Onesource Specialty Pharma (ONESOURCE) reported revenue ₹430 Cr and net profit ₹5 Cr — revenue +0.2% YoY. For annual financials, live price and key ratios, visit ONESOURCE share price.

ONESOURCE Quarterly Results — Revenue, Profit & EPS Highlights

Onesource Specialty Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review ONESOURCE P/E ratio to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹430 Cr in Mar 2026 (-5.1% vs Jun 2026, +0.2% vs Mar 2025)
  • Net Profit of ₹5 Cr in Mar 2026 (-80.0% vs Jun 2026, -94.9% vs Mar 2025)
  • EBITDA of ₹94 Cr in Mar 2026 (-23.6% vs Jun 2026)
  • Operating Margin of 21.0% in Mar 2026 (-6.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.40 in Mar 2026 (-81.7% vs Jun 2026)

Onesource Specialty Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ONESOURCE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 430 453 379 429 333 -5.1% 0.2%
Net Profit (₹ Cr) 5 25 11 99 0 - -
EBITDA (₹ Cr) 94 123 110 185 91 - -
EPS (₹) 0.40 2.18 0.92 8.61 -0.02 - -
Operating Margin (%) 21.0% 27.0% 28.0% 43.0% 26.0% - -

ONESOURCE Share Price Trend — 1-Year Movement Across Quarterly Results

Onesource Specialty Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Onesource Specialty Pharma networth to track the company's total market size over time.

Profitability Ratios

Profit Margin 1.2%
EBITDA Margin 21.9%
Operating Margin 21.0%
ROE (Annual) 0.3%

Balance Sheet Highlights

Total Assets ₹8,210 Cr
Total Equity ₹5,831 Cr
Current Assets ₹ Cr
Current Liabilities ₹937 Cr

Cash Flow Analysis

Operating Cash Flow ₹9 Cr
Investing Cash Flow ₹-495 Cr
Financing Cash Flow ₹359 Cr
Net Cash Flow ₹-127 Cr

Current Market Data

Current Price ₹1377.80
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 429
Sept 2025 379
Jun 2026 453
Mar 2026 430

Net Profit Trend (₹ Cr)

Mar 2025 99
Sept 2025 11
Jun 2026 25
Mar 2026 5

Operating Margin Trend (%)

Mar 2025 43.0%
Sept 2025 28.0%
Jun 2026 27.0%
Mar 2026 21.0%

ONESOURCE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Onesource Specialty Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores